Viral Molecular Diagnostics Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Instruments, Reagents); Application (AIDS, Hepatitis, Influenza, Respiratory Syncytial Virus, Others); End User (Hospitals, Diagnostic Laboratories, Others), and Geography

Report Code: TIPRE00021875 | No. of Pages: 150 | Category: Medical Device | Status: Upcoming

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!
MARKET INTRODUCTION

Rapid viral diagnosis in patient samples is easy due to molecular diagnostic techniques. They are also relatively inexpensive diagnostic methods that are highly sensitive and precise. For the diagnosis and epidemiological studies of human viral infections, immunological-based methods have been widely used.

MARKET DYNAMICS

The viral molecular diagnostics market is driving due to the increasing prevalence of viral diseases like hepatitis & influenza and rising geriatric population. However, high cost of molecular diagnostics is expected to hamper the growth of the global viral molecular diagnostics market.

MARKET SCOPE

The "Viral Molecular Diagnostics Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of viral molecular diagnostics market with detailed market segmentation by end user, application, and product type. The viral molecular diagnostics market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in viral molecular diagnostics market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The viral molecular diagnostics market is segmented on the basis of product type and end user. Based on type, the market is segmented as instruments and reagents. On the basis of application, the market is categorized as AIDS, hepatitis, influenza, respiratory syncytial virus, and others. On the basis of end user, the market is categorized as hospitals, diagnostic laboratories, and others.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Viral molecular diagnostics market based on various segments. It also provides market size and forecast estimates from year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Viral molecular diagnostics market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Viral molecular diagnostics market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Viral molecular diagnostics market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the Viral molecular diagnostics market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Viral molecular diagnostics market are anticipated to have lucrative growth opportunities in the future with the rising demand for Viral molecular diagnostics in the global market. Below mentioned is the list of few companies engaged in the Viral molecular diagnostics market.

The report also includes the profiles of key players in Viral molecular diagnostics market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •   Abbott Laboratories Inc.
  •   Affymetrix Inc.
  •   Auto Genomics Inc.
  •   Becton Dickinson and Company
  •   bioMérieux SA
  •   Hoffmann-La Roche Ltd.
  •   Illumina Inc.
  •   Meridian Bioscience Inc.
  •   Qiagen NV
  •   Thermo Fisher Scientific Corporation

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Viral Molecular Diagnostics Market - By Product Type
1.3.2 Viral Molecular Diagnostics Market - By Application
1.3.3 Viral Molecular Diagnostics Market - By End User
1.3.4 Viral Molecular Diagnostics Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. VIRAL MOLECULAR DIAGNOSTICS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. VIRAL MOLECULAR DIAGNOSTICS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. VIRAL MOLECULAR DIAGNOSTICS MARKET - GLOBAL MARKET ANALYSIS
6.1. VIRAL MOLECULAR DIAGNOSTICS - GLOBAL MARKET OVERVIEW
6.2. VIRAL MOLECULAR DIAGNOSTICS - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING
7. VIRAL MOLECULAR DIAGNOSTICS MARKET - REVENUE AND FORECASTS TO 2028 - PRODUCT TYPE
7.1. OVERVIEW
7.2. PRODUCT TYPE MARKET FORECASTS AND ANALYSIS
7.3. INSTRUMENTS
7.3.1. Overview
7.3.2. Instruments Market Forecast and Analysis
7.4. REAGENTS
7.4.1. Overview
7.4.2. Reagents Market Forecast and Analysis
8. VIRAL MOLECULAR DIAGNOSTICS MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. AIDS
8.3.1. Overview
8.3.2. AIDS Market Forecast and Analysis
8.4. HEPATITIS
8.4.1. Overview
8.4.2. Hepatitis Market Forecast and Analysis
8.5. INFLUENZA
8.5.1. Overview
8.5.2. Influenza Market Forecast and Analysis
8.6. RESPIRATORY SYNCYTIAL VIRUS
8.6.1. Overview
8.6.2. Respiratory Syncytial Virus Market Forecast and Analysis
8.7. OTHERS
8.7.1. Overview
8.7.2. Others Market Forecast and Analysis
9. VIRAL MOLECULAR DIAGNOSTICS MARKET - REVENUE AND FORECASTS TO 2028 - END USER
9.1. OVERVIEW
9.2. END USER MARKET FORECASTS AND ANALYSIS
9.3. HOSPITALS
9.3.1. Overview
9.3.2. Hospitals Market Forecast and Analysis
9.4. DIAGNOSTIC LABORATORIES
9.4.1. Overview
9.4.2. Diagnostic Laboratories Market Forecast and Analysis
9.5. OTHERS
9.5.1. Overview
9.5.2. Others Market Forecast and Analysis
10. VIRAL MOLECULAR DIAGNOSTICS MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Viral Molecular Diagnostics Market Overview
10.1.2 North America Viral Molecular Diagnostics Market Forecasts and Analysis
10.1.3 North America Viral Molecular Diagnostics Market Forecasts and Analysis - By Product Type
10.1.4 North America Viral Molecular Diagnostics Market Forecasts and Analysis - By Application
10.1.5 North America Viral Molecular Diagnostics Market Forecasts and Analysis - By End User
10.1.6 North America Viral Molecular Diagnostics Market Forecasts and Analysis - By Countries
10.1.6.1 United States Viral Molecular Diagnostics Market
10.1.6.1.1 United States Viral Molecular Diagnostics Market by Product Type
10.1.6.1.2 United States Viral Molecular Diagnostics Market by Application
10.1.6.1.3 United States Viral Molecular Diagnostics Market by End User
10.1.6.2 Canada Viral Molecular Diagnostics Market
10.1.6.2.1 Canada Viral Molecular Diagnostics Market by Product Type
10.1.6.2.2 Canada Viral Molecular Diagnostics Market by Application
10.1.6.2.3 Canada Viral Molecular Diagnostics Market by End User
10.1.6.3 Mexico Viral Molecular Diagnostics Market
10.1.6.3.1 Mexico Viral Molecular Diagnostics Market by Product Type
10.1.6.3.2 Mexico Viral Molecular Diagnostics Market by Application
10.1.6.3.3 Mexico Viral Molecular Diagnostics Market by End User
10.2. EUROPE
10.2.1 Europe Viral Molecular Diagnostics Market Overview
10.2.2 Europe Viral Molecular Diagnostics Market Forecasts and Analysis
10.2.3 Europe Viral Molecular Diagnostics Market Forecasts and Analysis - By Product Type
10.2.4 Europe Viral Molecular Diagnostics Market Forecasts and Analysis - By Application
10.2.5 Europe Viral Molecular Diagnostics Market Forecasts and Analysis - By End User
10.2.6 Europe Viral Molecular Diagnostics Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Viral Molecular Diagnostics Market
10.2.6.1.1 Germany Viral Molecular Diagnostics Market by Product Type
10.2.6.1.2 Germany Viral Molecular Diagnostics Market by Application
10.2.6.1.3 Germany Viral Molecular Diagnostics Market by End User
10.2.6.2 France Viral Molecular Diagnostics Market
10.2.6.2.1 France Viral Molecular Diagnostics Market by Product Type
10.2.6.2.2 France Viral Molecular Diagnostics Market by Application
10.2.6.2.3 France Viral Molecular Diagnostics Market by End User
10.2.6.3 Italy Viral Molecular Diagnostics Market
10.2.6.3.1 Italy Viral Molecular Diagnostics Market by Product Type
10.2.6.3.2 Italy Viral Molecular Diagnostics Market by Application
10.2.6.3.3 Italy Viral Molecular Diagnostics Market by End User
10.2.6.4 Spain Viral Molecular Diagnostics Market
10.2.6.4.1 Spain Viral Molecular Diagnostics Market by Product Type
10.2.6.4.2 Spain Viral Molecular Diagnostics Market by Application
10.2.6.4.3 Spain Viral Molecular Diagnostics Market by End User
10.2.6.5 United Kingdom Viral Molecular Diagnostics Market
10.2.6.5.1 United Kingdom Viral Molecular Diagnostics Market by Product Type
10.2.6.5.2 United Kingdom Viral Molecular Diagnostics Market by Application
10.2.6.5.3 United Kingdom Viral Molecular Diagnostics Market by End User
10.2.6.6 Rest of Europe Viral Molecular Diagnostics Market
10.2.6.6.1 Rest of Europe Viral Molecular Diagnostics Market by Product Type
10.2.6.6.2 Rest of Europe Viral Molecular Diagnostics Market by Application
10.2.6.6.3 Rest of Europe Viral Molecular Diagnostics Market by End User
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Viral Molecular Diagnostics Market Overview
10.3.2 Asia-Pacific Viral Molecular Diagnostics Market Forecasts and Analysis
10.3.3 Asia-Pacific Viral Molecular Diagnostics Market Forecasts and Analysis - By Product Type
10.3.4 Asia-Pacific Viral Molecular Diagnostics Market Forecasts and Analysis - By Application
10.3.5 Asia-Pacific Viral Molecular Diagnostics Market Forecasts and Analysis - By End User
10.3.6 Asia-Pacific Viral Molecular Diagnostics Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Viral Molecular Diagnostics Market
10.3.6.1.1 Australia Viral Molecular Diagnostics Market by Product Type
10.3.6.1.2 Australia Viral Molecular Diagnostics Market by Application
10.3.6.1.3 Australia Viral Molecular Diagnostics Market by End User
10.3.6.2 China Viral Molecular Diagnostics Market
10.3.6.2.1 China Viral Molecular Diagnostics Market by Product Type
10.3.6.2.2 China Viral Molecular Diagnostics Market by Application
10.3.6.2.3 China Viral Molecular Diagnostics Market by End User
10.3.6.3 India Viral Molecular Diagnostics Market
10.3.6.3.1 India Viral Molecular Diagnostics Market by Product Type
10.3.6.3.2 India Viral Molecular Diagnostics Market by Application
10.3.6.3.3 India Viral Molecular Diagnostics Market by End User
10.3.6.4 Japan Viral Molecular Diagnostics Market
10.3.6.4.1 Japan Viral Molecular Diagnostics Market by Product Type
10.3.6.4.2 Japan Viral Molecular Diagnostics Market by Application
10.3.6.4.3 Japan Viral Molecular Diagnostics Market by End User
10.3.6.5 South Korea Viral Molecular Diagnostics Market
10.3.6.5.1 South Korea Viral Molecular Diagnostics Market by Product Type
10.3.6.5.2 South Korea Viral Molecular Diagnostics Market by Application
10.3.6.5.3 South Korea Viral Molecular Diagnostics Market by End User
10.3.6.6 Rest of Asia-Pacific Viral Molecular Diagnostics Market
10.3.6.6.1 Rest of Asia-Pacific Viral Molecular Diagnostics Market by Product Type
10.3.6.6.2 Rest of Asia-Pacific Viral Molecular Diagnostics Market by Application
10.3.6.6.3 Rest of Asia-Pacific Viral Molecular Diagnostics Market by End User
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Viral Molecular Diagnostics Market Overview
10.4.2 Middle East and Africa Viral Molecular Diagnostics Market Forecasts and Analysis
10.4.3 Middle East and Africa Viral Molecular Diagnostics Market Forecasts and Analysis - By Product Type
10.4.4 Middle East and Africa Viral Molecular Diagnostics Market Forecasts and Analysis - By Application
10.4.5 Middle East and Africa Viral Molecular Diagnostics Market Forecasts and Analysis - By End User
10.4.6 Middle East and Africa Viral Molecular Diagnostics Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Viral Molecular Diagnostics Market
10.4.6.1.1 South Africa Viral Molecular Diagnostics Market by Product Type
10.4.6.1.2 South Africa Viral Molecular Diagnostics Market by Application
10.4.6.1.3 South Africa Viral Molecular Diagnostics Market by End User
10.4.6.2 Saudi Arabia Viral Molecular Diagnostics Market
10.4.6.2.1 Saudi Arabia Viral Molecular Diagnostics Market by Product Type
10.4.6.2.2 Saudi Arabia Viral Molecular Diagnostics Market by Application
10.4.6.2.3 Saudi Arabia Viral Molecular Diagnostics Market by End User
10.4.6.3 U.A.E Viral Molecular Diagnostics Market
10.4.6.3.1 U.A.E Viral Molecular Diagnostics Market by Product Type
10.4.6.3.2 U.A.E Viral Molecular Diagnostics Market by Application
10.4.6.3.3 U.A.E Viral Molecular Diagnostics Market by End User
10.4.6.4 Rest of Middle East and Africa Viral Molecular Diagnostics Market
10.4.6.4.1 Rest of Middle East and Africa Viral Molecular Diagnostics Market by Product Type
10.4.6.4.2 Rest of Middle East and Africa Viral Molecular Diagnostics Market by Application
10.4.6.4.3 Rest of Middle East and Africa Viral Molecular Diagnostics Market by End User
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Viral Molecular Diagnostics Market Overview
10.5.2 South and Central America Viral Molecular Diagnostics Market Forecasts and Analysis
10.5.3 South and Central America Viral Molecular Diagnostics Market Forecasts and Analysis - By Product Type
10.5.4 South and Central America Viral Molecular Diagnostics Market Forecasts and Analysis - By Application
10.5.5 South and Central America Viral Molecular Diagnostics Market Forecasts and Analysis - By End User
10.5.6 South and Central America Viral Molecular Diagnostics Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Viral Molecular Diagnostics Market
10.5.6.1.1 Brazil Viral Molecular Diagnostics Market by Product Type
10.5.6.1.2 Brazil Viral Molecular Diagnostics Market by Application
10.5.6.1.3 Brazil Viral Molecular Diagnostics Market by End User
10.5.6.2 Argentina Viral Molecular Diagnostics Market
10.5.6.2.1 Argentina Viral Molecular Diagnostics Market by Product Type
10.5.6.2.2 Argentina Viral Molecular Diagnostics Market by Application
10.5.6.2.3 Argentina Viral Molecular Diagnostics Market by End User
10.5.6.3 Rest of South and Central America Viral Molecular Diagnostics Market
10.5.6.3.1 Rest of South and Central America Viral Molecular Diagnostics Market by Product Type
10.5.6.3.2 Rest of South and Central America Viral Molecular Diagnostics Market by Application
10.5.6.3.3 Rest of South and Central America Viral Molecular Diagnostics Market by End User
11. IMPACT OF COVID-19 PANDEMIC ON GLOBAL VIRAL MOLECULAR DIAGNOSTICS MARKET
11.1 North America
11.2 Europe
11.3 Asia-Pacific
11.4 Middle East and Africa
11.5 South and Central America
12. INDUSTRY LANDSCAPE
12.1. MERGERS AND ACQUISITIONS
12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
12.3. NEW PRODUCT LAUNCHES
12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
13. VIRAL MOLECULAR DIAGNOSTICS MARKET, KEY COMPANY PROFILES
13.1. ABBOTT LABORATORIES INC.
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Products and Services
13.1.4. Financial Overview
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. AFFYMETRIX INC.
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Products and Services
13.2.4. Financial Overview
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. AUTO GENOMICS INC.
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Products and Services
13.3.4. Financial Overview
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. BECTON DICKINSON AND COMPANY
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Products and Services
13.4.4. Financial Overview
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. BIOMéRIEUX SA
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Products and Services
13.5.4. Financial Overview
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. HOFFMANN-LA ROCHE LTD.
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Products and Services
13.6.4. Financial Overview
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. ILLUMINA INC.
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Products and Services
13.7.4. Financial Overview
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. MERIDIAN BIOSCIENCE INC.
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Products and Services
13.8.4. Financial Overview
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. QIAGEN NV
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Products and Services
13.9.4. Financial Overview
13.9.5. SWOT Analysis
13.9.6. Key Developments
13.10. THERMO FISHER SCIENTIFIC CORPORATION
13.10.1. Key Facts
13.10.2. Business Description
13.10.3. Products and Services
13.10.4. Financial Overview
13.10.5. SWOT Analysis
13.10.6. Key Developments
14. APPENDIX
14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TERMS
The List of Companies

1. Abbott Laboratories Inc.
2. Affymetrix Inc.
3. Auto Genomics Inc.
4. Becton Dickinson and Company
5. bioMérieux SA
6. F. Hoffmann-La Roche Ltd.
7. Illumina Inc.
8. Meridian Bioscience Inc.
9. Qiagen NV
10. Thermo Fisher Scientific Corporation
11. Bio-Rad Laboratories
12. Olympus Corporation
13. Gen-Probe, Inc.
14. Viravaxx
15. MeMed
16. Adaltis
17. Microbix
TIPRE00021875
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking